Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_022601179.1 NSB1T_RS22660 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_000473955.1:WP_022601179.1 Length = 396 Score = 484 bits (1247), Expect = e-141 Identities = 242/391 (61%), Positives = 304/391 (77%), Gaps = 1/391 (0%) Query: 1 MTLLGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVIN 60 MT +GT L + +L GSGELGKEVAIE QR GVEV+A+D+Y +APAM VAHRS+V++ Sbjct: 1 MTKIGTTLSEVGKKALLCGSGELGKEVAIELQRYGVEVVALDKYPNAPAMQVAHRSYVLS 60 Query: 61 MLDGDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRL 120 MLDG LR ++E+EKP YI+PE+EAIAT L++LE+EG +V P A A LTMNREGIRRL Sbjct: 61 MLDGVRLREIIEVEKPDYIIPEVEAIATSTLVELEKEGFHVTPTANAAYLTMNREGIRRL 120 Query: 121 AAEELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKY 180 AAE L + TSTY+FA + F EAV IG PC+VKP+MSSSG GQ+ +RS + +AW+Y Sbjct: 121 AAETLGIKTSTYKFASTREEFNEAVKTIGVPCMVKPIMSSSGHGQSLVRSMADMDKAWQY 180 Query: 181 AQQGGRAGAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMS 240 AQ+GGRAGAGRVIVEG V FD+EITLLTV + G F P+GH Q DGDYRESWQPQ MS Sbjct: 181 AQEGGRAGAGRVIVEGFVDFDYEITLLTVRHIGGTAFLKPIGHHQVDGDYRESWQPQAMS 240 Query: 241 PLALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEF 300 AL+RA+EIA K+ ALGG+G+FGVELFV GD+VIFSEVSPRPHDTGMVT+ISQDLSEF Sbjct: 241 AEALKRAEEIAGKITNALGGWGIFGVELFVKGDDVIFSEVSPRPHDTGMVTMISQDLSEF 300 Query: 301 ALHVRAFLGLPVGGIRQYGPAASAVILPQLTSQNVTFDNVQNAVG-ADLQIRLFGKPEID 359 ALH RA LGLPV G+R Y P+AS I+ + + V FDN++ + D+Q+R+FGK E+ Sbjct: 301 ALHARAVLGLPVPGVRFYRPSASKAIVVEGDTDKVEFDNLEEVLSEPDVQLRIFGKAEVK 360 Query: 360 GSRRLGVALATAESVVDAIERAKHAAGQVKV 390 G RRLGV LA+A++V +A+ +A+ A ++K+ Sbjct: 361 GHRRLGVILASADTVEEALAKAERAYKKLKI 391 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 472 Number of extensions: 15 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 396 Length adjustment: 31 Effective length of query: 361 Effective length of database: 365 Effective search space: 131765 Effective search space used: 131765 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory